Member Info for Timster

have people not read through this??

https://avacta.com/wp-content/uploads/2020/09/Avacta-Group-plc-Interim-Results-September-2020-v2.pdf

seems fairly good to me, not at all PANIC PANIC EVERYTHING'S GONE TO ****E ITS TERRIBLE BLAH BLAH

more like, chill out, and if a third of the things that the presentation covers come off we will do very very well........

PLEASE MFM sell and move on! you must have a massive profit as you bought early but are still an incessant winger

bit rude @watching ;)

Boring.....

I'll have to listen again but although big Al made it clear this was not a simple process and not just box ticking. Fairly sure he said it would be done "quite quickly" (which could be months, or days :))

you've mixed up your products thats the BAMS test

Excellent presentation again by Avacta, no need to moan anymore everything explained perfectly!

I for one am very happy to be invested..

it did say it's being recorded so no issue with listening later

Sounds very good so far, apart from the boring cancer stuff ;)

strange reaction to information that we already knew! guess people bought into the hype that today was the big reveal!

Oh well, nothings changed Affimers still work and cancer treatments progressing...

At least tomorrow we'll get some clarity from Alastair. Not sure he'll be able to give us timescales as it's out of his hands. Looking forward to the meeting at 10.30

Still making no sense??

Spot on @SiriusB we need to remember this is interims. Especially tomorrow morning when the merry band of negateers turn up with the usual ******

This is not the news we are looking for. No LFT there

Not sure I trust the daily mail reporters.

Where's the pregnancy style test the government were banging on about. They must be looking at it to talk about it and we know prof Bell said there are four "pretty good" ones

Authorities around the world are now looking to carry-out frequent mass testing to identify the most infectious people promptly in order to reduce infection rates and combat the coronavirus pandemic. That requires a highly specific test to minimize false positives which would otherwise overwhelm healthcare systems. The Affimer reagents that we have generated are very specific to SARS-CoV-2 antigen and we are confident of meeting and exceeding the clinical performance requirements for identifying the most infectious people.



Manufacturing capacity is therefore the key challenge that has to be met in achieving widespread roll-out of Avacta's saliva-based rapid antigen test. We therefore continue to actively seek additional manufacturing partners globally to be able to provide the volume of tests that will be required in the UK and elsewhere. I look forward to updating the market on progress in that regard, and will keep the market informed on the key next steps of clinical validation and regulatory approval.

It works and it's getting validated

hopefully you've submitted your questions for Monday?

even if there are 4 approved the market is there..... The Market is the WORLD not just the UK

thanks Matml74, evaluating 4 "pretty good ones" at the moment

wonder what they could be

AGM's are scheduled well in advance so generally not planned around news. Unless it's SKIN.

Even if there is no RNS he will be able to elaborate on what's already been released.

@bladey we should hopefully get some timescales on Monday at the agm